Author:
Bancher C.,Jellinger K.,Wichart I.
Reference74 articles.
1. Arai H, Terajima M, Miura M, Higuchi S, Muramatsu T, Machida N, Seiki H, Takase S, Clark CM, Lee VM-Y, Trojanowski JQ, Sasaki A (1995) Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer’s disease. Ann Neurol 38: 649–652
2. Arai H, Higuchi S, Sasaki H (1997) Apolipoprotein E genotyping and cerebrospinal fluid tau protein — implications for the clinical diagnosis of Alzheimer’s disease. Gerontology 43 [Suppl 1]: 2–11
3. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 477: 90–99
4. Bancher C, Wisniewski HM, Mehta PD, Kim KS, Grundke-Iqbal I, Iqbal K (1991) Biochemical markers for Alzheimer’s disease as reflection of the neuropathology in cerebrospinal fluid. In: Becker RE, Giacobini E (eds) Current research in Alzheimer therapy II. Early diagnosis. Taylor and Francis, New York, pp 195–216
5. Blennow K, Hesse C, Fredman P (1994a) Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer’s disease. Neuro Report 5: 2534–2536
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献